{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T17:43:48Z","timestamp":1694627028522},"reference-count":70,"publisher":"Hindawi Limited","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3387,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1368-5031.2006.00856.x","type":"journal-article","created":{"date-parts":[[2006,5,24]],"date-time":"2006-05-24T11:31:12Z","timestamp":1148470272000},"page":"716-727","source":"Crossref","is-referenced-by-count":3,"title":["Statins and the acute coronary syndrome: \u2018the early bird catches the worm\u2019"],"prefix":"10.1155","volume":"60","author":[{"given":"P.","family":"Nair","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Roguin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2006,5,24]]},"reference":[{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1056\/NEJMoa044259","article-title":"Early invasive versus selectively invasive management for acute coronary syndromes","volume":"353","author":"Winter","year":"2005","journal-title":"New Engl J Med"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(02)09894-X","article-title":"Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart foundation RITA 3 randomised trial","volume":"360","author":"Fox","year":"2002","journal-title":"Lancet"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB3|cit3","first-page":"1383","article-title":"Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease. The Scandinavian Simvastatin Survival Study (4S)","volume":"344","author":"Group SSSS","year":"1994","journal-title":"Lancet"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group","volume":"333","author":"Shepherd","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. Results of AFCAPS\/TexCAPS. Air Force\/Texas Coronary Atherosclerosis Prevention Study","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","author":"The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group.","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0140-6736(05)63014-0","article-title":"Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20536 individuals","volume":"365","author":"Heart Protection Study Collaborative Group.","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.STR.28.5.946","article-title":"Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors","volume":"28","author":"Blauw","year":"1997","journal-title":"Stroke"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/archinte.1995.00430010054007","article-title":"An overview of trials of cholesterol lowering and risk of stroke","volume":"155","author":"Hebert","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB12|cit11","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/01.CIR.102.10.1193","article-title":"ACC\/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology\/American Heart Association task force on practice guidelines","volume":"102","author":"Braunwald","year":"2000","journal-title":"Circulation"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB13|cit12","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(00)05060-1","article-title":"Effect of glycoprotein IIb\/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial","volume":"357","author":"Simoons","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB14|cit13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1067\/mhj.2002.119767","article-title":"Mode and timing of treatment failure (recurrent ischemic events) after hospital admission for non-ST segment elevation acute coronary syndromes","volume":"143","author":"Cohen","year":"2002","journal-title":"Am Heart J"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB15|cit14","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1161\/01.CIR.100.15.1602","article-title":"TIMI 11B-ESSENCE meta-analysis","volume":"100","author":"Antman","year":"1999","journal-title":"Circulation"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB16|cit15","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1161\/01.CIR.0000025609.13806.31","article-title":"Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study","volume":"106","author":"Rioufol","year":"2002","journal-title":"Circulation"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB17|cit16","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1161\/01.ATV.0000032033.39301.6A","article-title":"Statin therapy in acute coronary syndromes: mechanistic insight into clinical benefit","volume":"22","author":"Sposito","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB18|cit17","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1161\/01.CIR.92.11.3172","article-title":"Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction","volume":"92","author":"Lacoste","year":"1995","journal-title":"Circulation"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB19|cit18","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S0735-1097(99)00018-2","article-title":"Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile","volume":"33","author":"Dangas","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB20|cit19","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1161\/01.CIR.94.6.1226","article-title":"Identification of active tissue factor in human coronary atheroma","volume":"94","author":"Marmur","year":"1996","journal-title":"Circulation"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB21|cit20","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(96)11189-2","article-title":"Tissue-factor antigen and activity in human coronary atherosclerotic plaques","volume":"349","author":"Ardissino","year":"1997","journal-title":"Lancet"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB22|cit21","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1161\/01.CIR.0000015465.73933.3B","article-title":"Statin prevents tissue factor expression in human endothelial cells. Role of Rho\/Rho kinase Akt pathways","volume":"105","author":"Eto","year":"2002","journal-title":"Circulation"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB23|cit22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1161\/01.ATV.14.1.41","article-title":"LDLs increase the exposure of fibrinogen binding sites on platelets and secretion of dense granules","volume":"14","author":"Van Willigen","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB24|cit23","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1001\/jama.279.20.1643","article-title":"Antiatherothrombotic properties of statins-implications for cardiovascular event reduction","volume":"279","author":"Rosenson","year":"1998","journal-title":"JAMA"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB25|cit24","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1161\/01.STR.31.10.2442","article-title":"Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice","volume":"31","author":"Laufs","year":"2000","journal-title":"Stroke"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB26|cit25","first-page":"1305","article-title":"The anti-thrombotic effects of statins","volume":"33","author":"Kearney","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB27|cit26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0195-668X(02)00419-0","article-title":"Statin effects beyond lipid lowering - Are they clinically relevant?","volume":"24","author":"Bonetti","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB28|cit27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1161\/01.ATV.15.2.247","article-title":"Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia","volume":"15","author":"Notarbartolo","year":"1995","journal-title":"Arterioscleros Thromb Vasc Biol"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB29|cit28","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(95)91322-X","article-title":"Vascular function in the forearm of hypercholesterolemic patients off and on lipid-lowering medication","volume":"346","author":"Stroes","year":"1995","journal-title":"Lancet"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB30|cit29","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1161\/01.CIR.99.25.3227","article-title":"Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial","volume":"99","author":"Dupuis","year":"1999","journal-title":"Circulation"},{"issue":"Suppl. III","key":"10.1111\/j.1368-5031.2006.00856.x-BIB31|cit30","first-page":"30","article-title":"Why do plaques rupture?","volume":"86","author":"Falk","year":"1992","journal-title":"Circulation"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB32|cit31","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.CIR.98.9.839","article-title":"Inflammation, pravastatin and the risk of coronary events after myocardial infarction in patients with average cholesterol levels","volume":"98","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB33|cit32","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/01.CIR.103.7.926","article-title":"Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques","volume":"103","author":"Crisby","year":"2001","journal-title":"Circulation"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB34|cit33","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0735-1097(97)00537-8","article-title":"Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys","volume":"31","author":"Williams","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB35|cit34","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/01.ATV.18.11.1671","article-title":"HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages","volume":"18","author":"Bellosta","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB36|cit35","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.CIR.100.3.230","article-title":"Long-term effects of pravastatin on plasma concentrations of C-reactive protein","volume":"100","author":"Ridker","year":"1999","journal-title":"Circulation"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB37|cit36","doi-asserted-by":"crossref","first-page":"304A","DOI":"10.1016\/S0735-1097(02)81367-5","article-title":"Effect of atorvastatin on C-reactive protein in patients with acute coronary syndromes: a substudy of the MIRACL trial","volume":"39","author":"Kinlay","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB38|cit37","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1161\/01.CIR.0000029743.68247.31","article-title":"Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction","volume":"106","author":"Plenge","year":"2002","journal-title":"Circulation"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB39|cit38","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/01.CIR.103.15.1933","article-title":"Effect of hydroxymethyl glutaryl coenzyme A reductase inhibitor therapy on high sensitive C-reactive protein","volume":"103","author":"Jialal","year":"2001","journal-title":"Circulation"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB40|cit39","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1001\/jama.285.4.430","article-title":"Early statin treatment following acute myocardial infarction and 1-year survival","volume":"285","author":"Stenestrand","year":"2001","journal-title":"JAMA"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB41|cit40","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0140-6736(00)04257-4","article-title":"Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study","volume":"357","author":"Aronow","year":"2001","journal-title":"Lancet"},{"issue":"Suppl.","key":"10.1111\/j.1368-5031.2006.00856.x-BIB42|cit41","first-page":"A316","article-title":"Lipid-lowering drug therapy initiated during hospitalization for acute MI is associated with lower postdischarge 1-year mortality","volume":"37","author":"Giugliano","year":"2001","journal-title":"Jam Coll Cardiol"},{"issue":"Suppl.","key":"10.1111\/j.1368-5031.2006.00856.x-BIB43|cit42","first-page":"A334","article-title":"Early statin therapy is associated with markedly lower mortality in patients with acute coronary syndromes: observations from OPUS-TIMI 16","volume":"37","author":"Cannon","year":"2001","journal-title":"J Am Collcardiol"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB44|cit43","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1161\/01.CIR.0000012530.68333.C8","article-title":"Withdrawal of statins increases event rates in patients with acute coronary syndromes","volume":"105","author":"Heeschen","year":"2002","journal-title":"Circulation"},{"issue":"Suppl. 1","key":"10.1111\/j.1368-5031.2006.00856.x-BIB45|cit44","first-page":"1","article-title":"The decisive importance of cholesterol lowering therapy for coronary lesions and clinical course immediately after and acute coronary event: short and long-term results of a controlled study","volume":"98","author":"Arntz","year":"1998","journal-title":"Circulation"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB46|cit45","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study: a randomized controlled trial","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB47|cit46","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0002-9149(02)02201-4","article-title":"Design of the pravastatin or atorvastatin evaluation and infection therapy (PROVE IT)-TIMI 22 trial","volume":"89","author":"Cannon","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB48|cit47","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB49|cit48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1067\/mhj.2001.116959","article-title":"The A-to-Z Trial: methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb\/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapy","volume":"142","author":"Blazing","year":"2001","journal-title":"Am Heart J"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB50|cit49","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1001\/jama.292.11.1365","article-title":"High-dose statins in acute coronary syndromes: not just lipid levels","volume":"292","author":"Nissen","year":"2004","journal-title":"JAMA"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB51|cit50","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1001\/jama.287.23.3087","article-title":"Early statin initiation and outcomes in patients with acute coronary syndromes","volume":"287","author":"Newby","year":"2002","journal-title":"JAMA"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB52|cit51","first-page":"III","article-title":"Reductions in early recurrent coronary ischemia from early administration of statin therapy upon admission for myocardial infarction: results of the PRINCESS trial","volume":"110","author":"LaBlanche","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB53|cit52","doi-asserted-by":"crossref","first-page":"4.","DOI":"10.1186\/1468-6708-6-4","article-title":"Fluvastatin in the therapy of acute coronary syndrome: rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)","volume":"6","author":"Ostadal","year":"2005","journal-title":"Curr Control Trials Cardiovasc Medical"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB54|cit53","unstructured":""},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB55|cit54","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1001\/jama.279.20.1643","article-title":"Antiatherothrombotic properties of statins: implications for cardiovascular event reduction","volume":"279","author":"Rosenson","year":"1998","journal-title":"JAMA"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB56|cit55","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1161\/01.CIR.96.5.1398","article-title":"Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial","volume":"96","author":"Wenke","year":"1997","journal-title":"Circulation"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB57|cit56","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM199509073331003","article-title":"Effect of pravastatin on outcomes after cardiac transplantation","volume":"333","author":"Kobashigawa","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB58|cit57","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/S0735-1097(97)00324-0","article-title":"HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia","volume":"30","author":"Weber","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB59|cit58","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0002-9149(97)00360-3","article-title":"Effectiveness of atorvastatin for reducing low-density lipoprotein cholesterol to National Cholesterol Education Program treatment goals","volume":"80","author":"Davidson","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB60|cit59","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","author":"Heart Protection Study Collaborative Group.","year":"2002","journal-title":"Lancet"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB61|cit60","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB62|cit61","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0735-1097(01)01135-4","article-title":"Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study","volume":"37","author":"Asakura","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB63|cit62","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1056\/NEJM200009283431303","article-title":"Multiple complex coronary plaques in patients with acute myocardial infarction","volume":"343","author":"Goldstein","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB64|cit63","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0005-2760(94)00176-Y","article-title":"Different effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors on sterol synthesis in various human cell types","volume":"1254","author":"Van Vliet","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB65|cit64","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0005-2760(90)90139-O","article-title":"Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor","volume":"1045","author":"Koga","year":"1990","journal-title":"Biochim Biophys Acta"},{"issue":"Pt 1","key":"10.1111\/j.1368-5031.2006.00856.x-BIB66|cit65","first-page":"G36","article-title":"Na(+)-independent multispecific anion transporter mediates active transport of pravastatin into rat liver","volume":"264","author":"Yamazaki","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB67|cit66","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0024-3205(00)00680-9","article-title":"Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: Reduction of mRNA levels for interleukin-1\u00df, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor a (PPARa) in primary endothelial cells","volume":"67","author":"Inoue","year":"2000","journal-title":"Life Sci"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB68|cit67","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0005-2760(96)00184-1","article-title":"Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types","volume":"1345","author":"N\u00e8gegre-Aminou","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB69|cit68","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0021-9150(93)90107-6","article-title":"Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase","volume":"101","author":"Corsini","year":"1993","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB70|cit69","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/01.RES.83.5.490","article-title":"3-hydroxy-3-methylglutaryl coenzyme A reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture","volume":"83","author":"Guijarro","year":"1998","journal-title":"Circ Res"},{"key":"10.1111\/j.1368-5031.2006.00856.x-BIB71|cit70","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00005344-200002000-00012","article-title":"Lipophilic HMG-CoA reductase inhibitors increase myocardial stunning in dogs","volume":"35","author":"Satoh","year":"2000","journal-title":"J Cardiovasc Pharmacol"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1368-5031.2006.00856.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1368-5031.2006.00856.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:04:25Z","timestamp":1643349865000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1368-5031.2006.00856.x"}},"subtitle":["STATINS IN ACS"],"short-title":[],"issued":{"date-parts":[[2006,5,24]]},"references-count":70,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.1111\/j.1368-5031.2006.00856.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5,24]]}}}